Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results
Last agilent technologies, inc earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
Highlights:Revenue of $1.27 billion represents 6 percent reported growth; and up 6 percent(1) on a core basis driven by strength in the pharma, diagnostics, environmental and forensics marketsGAAP net income of $191 million or EPS of $0.60Non-GAAP net income of $240 million or EPS of $0.76 (2), up 13 percent year-over-yearRaises full-year revenue and non-GAAP EPS guidanceSigned definitive agreement to acquire BioTek Instruments, a global leader in life science instrumentation, strengthening leadership position in the cell analysis segment SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.27 billion for the third quarter ended July 31, 2019, up 6 percent year-over-year (and up 6 percent on a core basis(1)).On a GAAP basis, third quarter net income was $191 million or $0.60 per share. This compares with $236 million or $0.73 per share in the third quarter of 2018. Non-GAAP net income(2) was $240 million or $0.76 per share during t
[Read more]
| Impact snapshot | Event time: | A | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
A alerts
A alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc news events
Weekly update
A roundup of the hottest topics
A
News
- Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D useBusiness Wire
- Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentralBusiness Wire
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from a "neutral" rating to a "bMarketBeat
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Redburn Partners from a "neutral" rating to a "buy" rating.MarketBeat
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
- More
A
SEC Filings
- 4/1/21 - Form 4
- 3/22/21 - Form 4
- 3/22/21 - Form 4
- A's page on the SEC website
- More